An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.

The American journal of managed care

Volumn 8, Issue 2 Suppl, 2002, Pages

  Stein, Evan A ^a  

^a Metabolic and Atherosclerosis Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINE DERIVATIVE; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

DRUG COMBINATION; HUMAN; HYPERCHOLESTEROLEMIA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA;

EID: 19244376646     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)